These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 26921826)

  • 1. PBT assessment and prioritization of contaminants of emerging concern: Pharmaceuticals.
    Sangion A; Gramatica P
    Environ Res; 2016 May; 147():297-306. PubMed ID: 26921826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PBT assessment and prioritization by PBT Index and consensus modeling: comparison of screening results from structural models.
    Gramatica P; Cassani S; Sangion A
    Environ Int; 2015 Apr; 77():25-34. PubMed ID: 25617903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case.
    Ortiz de García S; Pinto GP; García-Encina PA; Irusta Mata RI
    J Environ Manage; 2013 Nov; 129():384-97. PubMed ID: 23995140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hazard of pharmaceuticals for aquatic environment: Prioritization by structural approaches and prediction of ecotoxicity.
    Sangion A; Gramatica P
    Environ Int; 2016 Oct; 95():131-43. PubMed ID: 27568576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Pharmaceuticals on the Environment: Risk Assessment Using QSAR Modeling Approach.
    Kar S; Roy K; Leszczynski J
    Methods Mol Biol; 2018; 1800():395-443. PubMed ID: 29934904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are some "safer alternatives" hazardous as PBTs? The case study of new flame retardants.
    Gramatica P; Cassani S; Sangion A
    J Hazard Mater; 2016 Apr; 306():237-246. PubMed ID: 26742016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Greener chemicals for the future: QSAR modelling of the PBT index using ETA descriptors.
    De P; Roy K
    SAR QSAR Environ Res; 2018 Apr; 29(4):319-337. PubMed ID: 29457543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for PBT chemicals among the "existing" and "new" chemicals of the EU.
    Strempel S; Scheringer M; Ng CA; Hungerbühler K
    Environ Sci Technol; 2012 Jun; 46(11):5680-7. PubMed ID: 22494215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment for ecotoxicity of pharmaceuticals--an emerging issue.
    Kar S; Roy K
    Expert Opin Drug Saf; 2012 Mar; 11(2):235-74. PubMed ID: 22166011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated in silico strategy for PBT assessment and prioritization under REACH.
    Pizzo F; Lombardo A; Manganaro A; Cappelli CI; Petoumenou MI; Albanese F; Roncaglioni A; Brandt M; Benfenati E
    Environ Res; 2016 Nov; 151():478-492. PubMed ID: 27567352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental risk analysis and prioritization of pharmaceuticals in a developing world context.
    Mansour F; Al-Hindi M; Saad W; Salam D
    Sci Total Environ; 2016 Jul; 557-558():31-43. PubMed ID: 26994791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation.
    Besse JP; Garric J
    Toxicol Lett; 2008 Jan; 176(2):104-23. PubMed ID: 18077113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR modeling of cumulative environmental end-points for the prioritization of hazardous chemicals.
    Gramatica P; Papa E; Sangion A
    Environ Sci Process Impacts; 2018 Jan; 20(1):38-47. PubMed ID: 29226926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus QSAR modeling of toxicity of pharmaceuticals to different aquatic organisms: Ranking and prioritization of the DrugBank database compounds.
    Khan K; Benfenati E; Roy K
    Ecotoxicol Environ Saf; 2019 Jan; 168():287-297. PubMed ID: 30390527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental risk assessment of selected organic chemicals based on TOC test and QSAR estimation models.
    Chi Y; Zhang H; Huang Q; Lin Y; Ye G; Zhu H; Dong S
    J Environ Sci (China); 2018 Feb; 64():23-31. PubMed ID: 29478644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of human biotransformation QSARs and application for PBT assessment refinement.
    Papa E; Sangion A; Arnot JA; Gramatica P
    Food Chem Toxicol; 2018 Feb; 112():535-543. PubMed ID: 28412404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative survey of chemistry-driven in silico methods to identify hazardous substances under REACH.
    Nendza M; Gabbert S; Kühne R; Lombardo A; Roncaglioni A; Benfenati E; Benigni R; Bossa C; Strempel S; Scheringer M; Fernández A; Rallo R; Giralt F; Dimitrov S; Mekenyan O; Bringezu F; Schüürmann G
    Regul Toxicol Pharmacol; 2013 Aug; 66(3):301-14. PubMed ID: 23707536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction to special series: science-based guidance and framework for the evaluation and identification of PBTs and POPs.
    Klecka GM; Muir DC; Dohmen P; Eisenreich SJ; Gobas FA; Jones KC; Mackay D; Tarazona JV; van Wijk D
    Integr Environ Assess Manag; 2009 Oct; 5(4):535-8. PubMed ID: 19552505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling exposure to persistent chemicals in hazard and risk assessment.
    Cowan-Ellsberry CE; McLachlan MS; Arnot JA; Macleod M; McKone TE; Wania F
    Integr Environ Assess Manag; 2009 Oct; 5(4):662-79. PubMed ID: 19552503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.